Sunil Healthcare (BOM:537253) Research & Development: ₹0.0 Mil (TTM As of Mar. 2026)


BOM:537253 Sunil Healthcare Ltd BOM:537253
52 GF Score
Price ₹68.45
GF Value ₹71.26
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Sunil Healthcare Research & Development?

Sunil Healthcare BOM:537253 +2.15% 52 Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus rates BOM:537253 with a GF Score™ of 52/100 and a GF Value™ of ₹71.26 (Fairly Valued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Sunil Healthcare's Research & Development for the three months ended in Mar. 2026 was ₹0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₹0.0 Mil.

Sunil Healthcare  (BOM:537253) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Sunil Healthcare Research & Development Related Terms

Sunil Healthcare Research & Development Historical Data

* Premium members only.

The historical data trend for Sunil Healthcare's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sunil Healthcare Research & Development Chart

Sunil Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Sunil Healthcare Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
BOM:537253
52GF Score
Sunil Healthcare Ltd BOM:537253
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sunil Healthcare Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₹0.0 Mil mean?
Sunil Healthcare (BOM:537253) has a Research & Development of ₹0.0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on Sunil Healthcare and its competitors.
Is Sunil Healthcare's Research & Development too high?
Sunil Healthcare's current Research & Development is ₹0.0 Mil. Overall, Sunil Healthcare has a GF Score™ of 52/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Sunil Healthcare's Research & Development compare to ZTS and UTHR?
Sunil Healthcare's Research & Development of ₹0.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Sunil Healthcare and its competitors. Sunil Healthcare's current Research & Development is ₹0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunil Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Sunil Healthcare (BOM:537253) is currently considered Fairly Valued. The stock's GF Value™ is ₹71.26, compared to a current price of ₹68.45 — trading 3.9% below its estimated fair value. The current Research & Development is ₹0.0 Mil. Sunil Healthcare's overall GF Score™ is 52/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Sunil Healthcare (BOM:537253), the current Research & Development is ₹0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sunil Healthcare (BOM:537253) Overvalued in 2026?

Based on GuruFocus' analysis, Sunil Healthcare stock appears to be undervalued. The current stock price of ₹68.45 is trading 3.9% below its estimated GF Value™ of ₹71.26. GuruFocus considers Sunil Healthcare to be Fairly Valued.

Key valuation signals for BOM:537253:

  • Research & Development: ₹0.0 Mil
  • GF Value™: ₹71.26 vs. price of ₹68.45 (3.9% below fair value)
  • GF Score™: 52/100 with 7 warning signs

No single metric tells the full story. See the BOM:537253 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sunil Healthcare Business Description

Address 38E/252 - A, Vijay Tower, 3rd Floor, Opposite Panchsheel Commercial Complex, Shahpurjat, New Delhi, IND, 110049
Sunil Healthcare Ltd manufactures hard gelatin capsule shells that are used by pharmaceutical and food supplement companies. It operates in a single segment, that is, Empty Capsules. The company manufactures nine different sizes of capsules. Its products include BSE Free Capsules, Pearl Capsules, Liquid Fill Capsules, Stick Free Capsules, and Preservative Free Capsules. The company generates the majority of its revenue from India.
52GF Score

Get the complete analysis for BOM:537253

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹68.45
Price
₹71.26
GF Value